FDA product code OVG: Magnetic Cell Selection System For Cd34+ Cells From Hpc-Apheresis Used In Treatment Of Acute Myeloid Leukemia (Aml)

OVG is the FDA product code for magnetic cell selection system for cd34+ cells from hpc-apheresis used in treatment of acute myeloid leukemia (aml). It is a HDE device, reviewed by the Hematology panel. Devices under OVG reach the market by Unclassified; FDA lists no cleared 510(k)s for it.

Definition

For processing hematopoietic progenitor cells-apheresis (HPC-A) from an HLA-identical donor to obtain a CD34 positive cell enriched population that will provide for hematopoietic reconstitution following a myeloablative preparative regimen without the need for additional graft-vs-host disease (GVHD) prophylaxis.

Classification

FieldValue
Device nameMagnetic Cell Selection System For Cd34+ Cells From Hpc-Apheresis Used In Treatment Of Acute Myeloid Leukemia (Aml)
Device classHDE
Review panelHE — Hematology
Medical specialtyUnknown
Premarket routeUnclassified

Recalls for OVG devices

FDA recall records list no recalls for product code OVG.

Frequently asked questions

What is FDA product code OVG?

OVG is the FDA product code for magnetic cell selection system for cd34+ cells from hpc-apheresis used in treatment of acute myeloid leukemia (aml). It is a HDE device, reviewed by the Hematology panel.

What device class is OVG?

HDE. Typical premarket route: Unclassified.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times